MXCT vs UTHR · rev $38.6M vs P/E 20, rev $2.88B
MaxCyte Inc (MXCT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
MXCT currently screens at market cap $124.3M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the MXCT and UTHR stock pages for the full models.
Not investment advice.